脑血管反应性与阿尔茨海默病理标志物及认知表现的关联
这项横断面研究纳入72名老年人(认知正常28人,认知障碍44人),用高碳酸血症MRI测量全脑脑血管反应性(CVR),并检测脑脊液Aβ42和tau。结果显示,校正AD病理标志物后,全脑CVR仍与MoCA评分和全局认知复合评分独立相关;在预测MoCA时,仅CVR显著,而Fazekas评分和血管风险评分不显著。
要点
- 全脑CVR与认知表现独立于AD病理标志物相关。
- 认知障碍组全脑CVR低于认知正常组。
- CVR可能作为评估血管性认知障碍的生物标志物。
核心结论
- 全脑CVR与认知表现显著相关,且独立于AD病理标志物。
研究设计与样本
- 横断面研究,纳入72名69±8岁参与者,其中认知正常28人,认知障碍44人(含MCI 36人,轻度痴呆8人)。
- CVR通过高碳酸血症MRI测量,以全脑BOLD信号每1 mmHg Etco2变化百分比表示。
- 认知评估包括MoCA、认知域评分和全局认知复合评分;AD生物标志物包括脑脊液Aβ42和tau检测。
主要发现
- 认知障碍组全脑CVR低于认知正常组(0.132±0.006%/mmHg vs 0.151±0.007%/mmHg;β=-0.02%/mmHg,95%CI -0.038至-0.001)。
- 校正脑脊液Aβ42和tau后,较高的全脑CVR与更好的MoCA表现相关(β=29.64,95%CI 9.94-49.34)。
- 校正后,较高的全脑CVR与更好的全局认知复合评分相关(β=4.32,95%CI 0.05-8.58)。
- 在预测MoCA的单一回归模型中,仅CVR显示显著效应(β=28.09,95%CI 6.14-50.04),Fazekas评分和血管风险评分不显著。
临床怎么用
- 在老年人群中,全脑CVR可作为评估血管性疾病相关认知障碍的潜在生物标志物。
- 解读认知障碍患者的CVR时,需考虑其独立于AD病理的附加信息价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether MRI-based cerebrovascular reactivity (CVR) can predict cognitive performance independently of Alzheimer pathologic markers, we studied the relationship between cognition, CVR, and CSF-derived β-amyloid42 (Aβ42) and tau in a group of elderly individuals with mixed Alzheimer and vascular cognitive impairment and dementia. METHODS: This was a cross-sectional study of 72 participants 69 ± 8 years of age consisting of individuals with normal cognition (n = 28) and cognitive impairment (n = 44) (including 36 with mild cognitive impairment [MCI] and 8 with mild dementia). CVR was measured with hypercapnia-MRI. Whole-brain CVR (percent blood oxygen level-dependent per 1 mm Hg Etco2) was used to estimate vasodilatory capacity. Montreal Cognitive Assessment (MoCA) scores, cognitive domains scores, and a global composite cognitive score were obtained. AD biomarkers included CSF assays of Aβ42 and tau. RESULTS: Whole-brain CVR was lower in the impaired (mean ± SE, 0.132 ± 0.006%/mm Hg) compared to the normal (0.151 ± 0.007%/mm Hg) group (β = -0.02%/mm Hg; 95% confidence interval [CI] -0.038 to -0.001). After adjustment for CSF Aβ42 and tau, higher whole-brain CVR was associated with better performance on the MoCA (β = 29.64, 95% CI 9.94-49.34) and with a global composite cognitive score (β = 4.32, 95% CI 0.05-8.58). When the CVR marker was compared with the Fazekas score based on white matter hyperintensities and vascular risk-score in a single regression model predicting the MoCA score, only CVR revealed a significant effect (β = 28.09, 95% CI 6.14-50.04), while the other 2 measures were not significant. CONCLUSIONS: CVR was significantly associated with cognitive performance independently of AD pathology. Whole-brain CVR may be a useful biomarker for evaluating cognitive impairment related to vascular disease in older individuals. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that CVR was significantly associated with cognitive performance independent of AD pathology.
引用
- Sur S, Lin Z, Li Y, et al. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology. 2020. PMID: 32661101. doi:10.1212/WNL.0000000000010133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。